A mitochondrial targeted fusion peptide exhibits remarkable cytotoxicity

112Citations
Citations of this article
59Readers
Mendeley users who have this article in their library.

Abstract

A potent cytotoxic peptide (r7-kla) was synthesized by incorporating a mitochondrial membrane disrupting peptide, kla (klaklakklaklak), with a cell-penetrating domain, r7 (rrrrrrr). The IC50 of r7-kla (3.54 ± 0.11 μmol/L) was more than two orders of magnitude lower than that of kla. r7-kla induced cell death in both in vitro and in vivo environments, and showed rapid kinetics. Within minutes, the morphologic changes in cells and mitochondrial leakage were apparent by microscopy and was consistent with rapid apoptosis. Our results suggested that r7-kla is an apoptosis inducer and can be potentially used as an antitumor agent, especially when combined with the appropriate systemic delivery systems. Copyright © 2006 American Association for Cancer Research.

Cite

CITATION STYLE

APA

Law, B., Quinti, L., Choi, Y., Weissleder, R., & Tung, C. H. (2006). A mitochondrial targeted fusion peptide exhibits remarkable cytotoxicity. Molecular Cancer Therapeutics, 5(8), 1944–1949. https://doi.org/10.1158/1535-7163.MCT-05-0509

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free